21甾体成分研究'> 青阳参中C21甾体成分研究

时间:2022-08-03 06:59:34

21甾体成分研究'> 青阳参中C21甾体成分研究

[摘要] 该文用硅胶,ODS,MCI柱色谱和半制备型HPLC等方法对青阳参的氯仿萃取中含有的C21甾体类成分进行了系统的分离纯化研究,并结合波谱数据对该类成分进行了结构确认。从青阳参氯仿萃取物分离到11个C21甾体类化合物,分别为青阳参苷乙(1),告达亭-3-O-β-D-加拿大麻吡喃糖基-(14)-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷(2),告达亭-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷(3),告达亭-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-毛地黄毒吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷(4),青阳参苷O(5),加加明-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷(6), sinomarinoside B(7),mucronatosides C(8),wallicoside J(9),stephanoside H(10),青阳参苷元-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-毛地黄毒吡喃糖苷(11)。 除化合物1,4和5外其他成分均为首次从该植物中分离得到的C21甾体类化合物。

[关键词] 青阳参; C21甾体;青阳参苷乙

[收稿日期] 2013-10-23

[基金项目] 国家自然科学基金项目(31160065)

[通信作者] 李宝才,教授,博士,研究方向为天然产物开发利用,E-mail: ;,助理教授,博士,研究方向中药活性评价及质量控制,E-mail:

[作者简介] 李祥,硕士研究生, E-mail:

青阳参Cynanchum otophyllum Schneid为萝藦科鹅绒藤属植物主要分布于我国西南部,是著名的云南民间药物。其药用部位为根部,具有祛风湿、益肾健脾之功效,主要用于治疗风湿痹疼、肾虚腰疼、腰肌劳损、蛇犬咬伤等[1]。在云南纳西族和白族地区,青阳参主要用于治疗癫痫[2]。目前青阳参的氯仿提取物已开发成为治疗癫痫的上市药物,其主要有效成分为C21甾体类化合物[3-4]。20世纪80年代至今,木全章、赵益斌等人先后从青阳参中分离得到40多个C21甾体类化合物[4-8]。国内有学者研究发现:青阳参有明显的抗癫痫作用,且具有作用时间持久、副作用少,与其他抗惊厥药联用无明显不良反应的特点,对顽固性癫痫大发作不失为一个有前途的新的抗癫痫药,其中青阳参苷甲和青阳参苷乙是青阳参中抗癫痫的活性成分之一[9]。但总的来说,青阳参植物抗癫痫的活性成分研究仍集中在总提取物或有效部位(如总苷)层面。为进一步明确其中单体活性成分,本论文采用多种分离方法从其根部的氯仿萃取物中分离并鉴定出11 个C21甾体类化合物。除化合物1,4和5外其他成分均为首次从青阳参植物中分离到。

1 材料

BRUKER DRX-500型核磁共振仪内标物为TMS;柱色谱硅胶(100~200,200~300目)和薄层色谱硅胶GF254均为青岛海洋化工厂产品。显色剂为10%的硫酸-乙醇。半制备HPLC为LC 3000液相色谱仪;半制备柱为Zorbax SB-C18(9.4 mm × 250 mm,0.5 μm)。 青阳参药材购自昆明市村中药材市场并由云南省中医中药研究所郭世民研究员鉴定为青阳参C. otophyllum的干燥块根。

2 提取与分离

青阳参干燥根9.0 kg粉碎后用75%乙醇在80 ℃水浴中回流提取3次每次4 h。滤液浓缩成浸膏加水混悬依次用石油醚脱、氯仿萃取得到氯仿萃取物240.0 g。取氯仿萃取物200.0 g经硅胶柱色谱(氯仿-甲醇40∶1~10∶1)得到Fr.1(40.0 g),Fr.2(55.0 g),Fr.3(62.0 g)和Fr.4(30.0 g)。 Fr.1(6.0 g)经MCI柱色谱(甲醇-水85∶15~80∶20)得到Fr.1a,Fr.1b,Fr.1c和Fr.1d。 Fr.1a经半制备HPLC(甲醇-水85∶15)得到3(21.4 mg,tR=8.5 min)。 Fr.1c经ODS柱色谱(甲醇-水83∶17)得到Fr.1c1,Fr.1c2和Fr.1c3其中Fr.1c2经半制备HPLC(甲醇-水82∶18)得到1(10.5 mg,tR=16.4 min)和4(14.0 mg,tR=25.4 min)。 Fr.2(6.0 g)经MCI柱色谱(甲醇-水83∶17)得到Fr.2a,Fr.2b和Fr.2c。Fr.2a经半制备HPLC(甲醇-水81∶19)得到2(30.4 mg,tR=20.8 min)。Fr.2b经ODS柱色谱(甲醇-水81∶19)得到Fr.2b1和Fr.2b2。 Fr.2b1经半制备HPLC(甲醇-水81∶19)得到6(12.5 mg,tR=18.5min)。 Fr.2b2 经半制备HPLC(甲醇-水79∶21)得到7(32.5 mg,tR=32.4 min)和9(8.8 mg,tR=27.8 min)。 Fr.3(5.0 g)经ODS柱色谱(甲醇-水80∶20~75∶25)得到Fr.3a,Fr.3b,Fr.3c 和 Fr.3d。Fr.3a经ODS柱色谱(甲醇-水79∶21)得到Fr.3a1和Fr.3a2。Fr.3a2经半制备HPLC(甲醇-水78∶22)得到5(20.6 mg,tR=29.7 min)。 Fr.3b经半制备HPLC(甲醇-水78∶22)得到10(33.6 mg,tR=35.4 min)。 Fr.3c经半制备HPLC(甲醇-水77∶23)得到8(9.6 mg,tR=27.4 min)和11(30.1 mg,tR=29.8 min)。

3 结构鉴定

化合物1 白色不定型粉末;1H-NMR(CDCl3,500 MHz)δ:3.53(1H,m,H-3),5.35(1H,s,H-6),4.53(1H,m,H-12),1.39(3H,s,H-18),1.11(3H,s,H-19),2.15(3H,s,H-21),5.50(1H,s,H-2′),2.34(1H,m,H-4′),1.05(3H,s,H-5′),1.04(3H,s,H-6′),2.11(3H,s,H-7′),4.83(1H,d,J=9.5 Hz,H-1″),3.80(1H,m,H-3″),3.20(1H,m,H-4″),3.86(1H,m,H-5″),1.20(3H,d,J=4.0 Hz,H-6″),3.43(3H,s,H-7″),4.74(1H,d,J=9.5 Hz,H-1),3.79(1H,m,H-3),3.22(1H,m,H-4),3.84(1H,m,H-5),1.21(3H,d,J= 4.0 Hz,H-6),3.43(3H,s,H-7),4.48(1H,d,J=10.0 Hz,H-1″″),3.17(1H,m,H-3″″),3.12(1H,m,H-4″″),3.28(1H,m,H-5″″),1.30(3H,d,J=4.0 Hz,H-6″″),3.37(3H,s,H-7″″);13C-NMR(CDCl3,125 MHz)δ: 38.7(C-1),28.8(C-2),77.8(C-3),38.7(C-4),140.6(C-5),117.6(C-6),34.2(C-7),74.2(C-8),43.6(C-9),37.1(C-10),24.2(C-11),71.5(C-12),57.9(C-13),88.0(C-14),33.0(C-15),31.8(C-16),91.5(C-17),9.4(C-18),18.5(C-19),208.9(C-20),27.2(C-21),166.9(C-1′),112.9(C-2′),165.9(C-3′),38.1(C-4′),20.9(C-5′),20.8(C-6′),16.5(C-7′),96.0(C-1″),35.4(C-2″),76.9(C-3″),82.4(C-4″),68.3(C-5″),18.2(C-6″),58.1(C-7″),99.6(C-1),35.3(C-2),76.9(C-3),82.4(C-4),68.3(C-5),18.2(C-6),58.0(C-7),101.4(C-1″″),35.2(C-2″″),80.5(C-3″″),75.3(C-4″″),71.5(C-5″″),18.0(C-6″″),56.3(C-7″″)。以上数据与文献[10]对照鉴定该化合物为青阳参苷元乙。

化合物2 白色不定型粉末;1H-NMR(CDCl3,500 MHz)δ:3.56(1H,m,H-3),5.35(1H,s,H-6),4.53(1H,m,H-12),1.36(3H,s,H-18),1.11(3H,s,H-19),2.11(3H,s,H-21),5.50(1H,s,H-2′),2.34(1H,m,H-4′),1.05(3H,s,H-5′),1.04(3H,s,H-6′),2.15(3H,s,H-7′),4.86(1H,d,J=9.5 Hz,H-1″),3.78(1H,m,H-3″),3.21(1H,m,H-4″),3.86(1H,m,H-5″),1.20(3H,d,J= 4.0 Hz,H-6″),3.43(3H,s,H-7″),4.73(1H,d,J= 9.5 Hz,H-1),3.79(1H,m,H-3),3.21(1H,m,H-4),3.85(1H,m,H-5),1.20(3H,d,J= 4.0 Hz,H-6),3.43(3H,s,H-7),4.44(1H,d,J=10.0 Hz,H-1″″),3.26(1H,m,H-3″″),3.15(1H,m,H-4″″),3.35(1H,m,H-5″″),1.28(3H,d,J=4.5 Hz,H-6″″),3.39(3H,s,H-7″″),4.84(1H,d,J=9.5 Hz,H-1″),3.61(1H,m,H-3″),3.20(1H,m,H-4″),3.55(1H,m,H-5″),1.28(3H,d,J=4.0 Hz,H-6″),3.41(3H,s,H-7″);13C-NMR(CDCl3,125 MHz)δ:38.7(C-1),28.8(C-2),77.8(C-3),38.6(C-4),140.7(C-5),117.6(C-6),34.2(C-7),74.2(C-8),43.6(C-9),37.1(C-10),24.2(C-11),72.3(C-12),57.9(C-13),88.0(C-14),33.0(C-15),31.8(C-16),91.5(C-17),9.4(C-18),18.5(C-19),208.9(C-20),27.2(C-21),166.9(C-1′),112.9(C-2′),165.9(C-3′),38.1(C-4′),21.0(C-5′),20.9(C-6′),16.5(C-7′),96.0(C-1″),35.4(C-2″),77.0(C-3″),82.5(C-4″),68.5(C-5″),18.2(C-6″),58.2(C-7″),99.6(C-1),35.4(C-2),76.9(C-3),82.4(C-4),68.3(C-5),18.2(C-6),58.0(C-7),101.3(C-1″″),36.2(C-2″″),78.8(C-3″″),82.1(C-4″″),71.0(C-5″″),18.2(C-6″″),56.4(C-7″″),98.2(C-1″),33.7(C-2″),77.4(C-3″),71.5(C-4″),71.0(C-5″),18.2(C-6″),57.1(C-7″)。以上数据与文献[11]对照鉴定该化合物为告达亭-3-O-β-D-加拿大麻吡喃糖基-(14)-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷。

化合物3 白色不定型粉末;1H-NMR(CDCl3,500 MHz)δ:3.53(1H,m,H-3),5.33(1H,s,H-6),4.50(1H,m,H-12),1.37(3H,s,H-18),1.09(3H,s,H-19),2.14(3H,s,H-21),5.48(1H,s,H-2′),2.30(1H,m,H-4′),1.03(3H,s,H-5′),1.01(3H,s,H-6′),2.09(3H,s,H-7′),4.80(1H,d,J=10.0 Hz,H-1″),3.77(1H,m,H-3″),3.19(1H,m,H-4″),3.81(1H,m,H-5″),1.18(3H,d,J=4.5 Hz,H-6″),3.41(3H,s,H-7″),4.71(1H,d,J=9.5 Hz,H-1),3.78(1H,m,H-3),3.20(1H,m,H-4),3.83(1H,m,H-5),1.18(3H,d,J=4.0 Hz,H-6),3.40(3H,s,H-7),4.42(1H,d,J=10.0 Hz,H-1″″),3.29(1H,m,H-3″″),3.17(1H,m,H-4″″),3.27(1H,m,H-5″″),1.31(3H,d,J=4.5 Hz,H-6″″),3.36(3H,s,H-7″″),4.68(1H,d,J=9.5 Hz,H-1″),3.16(1H,m,H-3″),3.13(1H,m,H-4″),3.28(1H,m,H-5″),1.35(3H,d,J=4.0 Hz,H-6″),3.36(3H,s,H-7″);13C-NMR(CDCl3,125 MHz)δ:38.7(C-1),28.8(C-2),77.8(C-3),38.6(C-4),140.5(C-5),117.8(C-6),34.1(C-7),74.2(C-8),43.6(C-9),37.0(C-10),24.2(C-11),71.6(C-12),57.8(C-13),88.0(C-14),33.0(C-15),31.8(C-16),91.4(C-17),9.3(C-18),18.4(C-19),208.9(C-20),27.1(C-21),166.8(C-1′),112.8(C-2′),165.9(C-3′),38.1(C-4′),20.8(C-5′),20.8(C-6′),16.4(C-7′),96.0(C-1″),35.4(C-2″),77.0(C-3″),82.4(C-4″), 68.2(C-5″),18.1(C-6″),57.9(C-7″),99.6(C-1),35.4(C-2),76.9(C-3),82.3(C-4),68.5(C-5),18.3(C-6),58.1(C-7),101.3(C-1″″),36.1(C-2″″),79.0(C-3″″),82.1(C-4″″),71.9(C-5″″),18.1(C-6″″),56.5(C-7″″),100.1(C-1″),35.4(C-2″),80.0(C-3″),75.3(C-4″),70.9(C-5″),17.9(C-6″),56.3(C-7″)。以上数据与文献[11]对照鉴定该化合物为告达亭-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷。

化合物4 白色不定型粉末;1H-NMR(CDCl3,500 MHz)δ:3.57(1H,m,H-3),5.37(1H,s,H-6),4.56(1H,m,H-12),1.42(3H,s,H-18),1.13(3H,s,H-19),2.18(3H,s,H-21),5.53(1H,s,H-2′),2.36(1H,m,H-4′),1.08(3H,s,H-5′),1.06(3H,s,H-6′),2.13(3H,s,H-7′),4.83(1H,d,J=9.5 Hz,H-1″),3.82(1H,m,H-3″),3.23(1H,m,H-4″),3.93(1H,m,H-5″),1.23(3H,d,J=4.0 Hz,H-6″),3.47(3H,s,H-7″),4.93(1H,d,J=10.0 Hz,H-1),4.26(1H,m,H-3),3.18(1H,m,H-4),3.78(1H,m,H-5),1.25(3H,d,J=4.0 Hz,H-6),4.51(1H,d,J=10.0 Hz,H-1″″),3.17(1H,m,H-3″″),3.13(1H,m,H-4″″),3.32(1H,m,H-5″″),1.34(3H,d,J=4.0 Hz,H-6″″),3.40(3H,s,H-7″″); 13C-NMR(CDCl3,125 MHz)δ:38.7(C-1),28.8(C-2),77.8(C-3),38.7(C-4),140.6(C-5),117.6(C-6),34.4(C-7),74.3(C-8),43.6(C-9),37.1(C-10),24.2(C-11),71.5(C-12),57.8(C-13),88.0(C-14),33.0(C-15),31.9(C-16),91.5(C-17),9.4(C-18),18.6(C-19),208.9(C-20),27.5(C-21),166.8(C-1′),112.9(C-2′),165.9(C-3′),38.1(C-4′),20.9(C-5′),20.8(C-6′),16.5(C-7′),95.7(C-1″),35.2(C-2″),76.8(C-3″),82.3(C-4″),68.0(C-5″),18.2(C-6″),58.3(C-7″),98.4(C-1),37.0(C-2),68.6(C-3),82.4(C-4),66.3(C-5),18.2(C-6),101.4(C-1″″),35.4(C-2″″),80.5(C-3″″),75.3(C-4″″),71.5(C-5″″),18.0(C-6″″),56.3(C-7″″)。以上数据与文献[12]对照鉴定该化合物为告达亭-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-毛地黄毒吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷。

化合物5 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.84(1H,m,H-3),5.26(1H,s,H-6),5.32(1H,dd,J=4.0,11.5 Hz,H-12),2.08(3H,s,H-18),1.29(3H,s,H-19),2.41(3H,s,H-21),8.28(1H,d,J=8.5 Hz,H-3′),7.26(1H,d,J=8.5 Hz,H-4′),7.26(1H,d,J=8.5 Hz,H-6′),8.28(1H,d,J=8.5 Hz,H-7′),5.28(1H,d,J=9.5 Hz,H-1″),4.08(1H,m,H-3″),3.53(1H,m,H-4″),4.21(1H,m,H-5″),1.38(3H,d,J=6.0 Hz,H-6″),3.61(3H,s,H-7″),5.11(1H,d,J=9.5 Hz,H-1),4.01(1H,m,H-3),3.45(1H,m,H-4),4.17(1H,m,H-5),1.38(3H,d,J=6.0 Hz,H-6),3.56(3H,s,H-7),4.70(1H,d,J=10.0 Hz,H-1″″),3.58(1H,m,H-3″″),3.50(1H,m,H-4″″),3.53(1H,m,H-5″″),1.45(3H,d,J=4.5 Hz,H-6″″),3.47(3H,s,H-7″″),5.26(1H,d,J=9.5 Hz,H-1″),3.78(1H,m,H-3″),3.53(1H,m,H-4″),4.12(1H,m,H-5″),1.54(3H,d,J=5.5 Hz,H-6″),3.47(3H,s,H-7″); 13C-NMR(pyridine-d5,125 MHz)δ: 39.4(C-1),29.9(C-2),77.8(C-3),39.0(C-4),139.5(C-5),119.1(C-6),34.9(C-7),74.5(C-8),44.6(C-9),37.5(C-10),25.2(C-11),73.3(C-12),58.5(C-13),89.7(C-14),34.0(C-15),33.2(C-16),92.6(C-17),10.9(C-18),18.2(C-19),209.4(C-20),27.9(C-21),165.5(C-1′),119.1(C-2′),132.5(C-3′),116.3(C-4′),163.7(C-5′),116.3(C-6′),132.5(C-7′),96.5(C-1″),37.2(C-2″),78.1(C-3″),83.5(C-4″),69.1(C-5″),18.7(C-6″),58.9(C-7″),100.3(C-1),37.0(C-2),77.9(C-3),83.2(C-4),69.0(C-5),18.6(C-6),59.0(C-7),102.0(C-1″″),37.7(C-2″″),79.0(C-3″″),82.8(C-4″″),71.9(C-5″″),18.7(C-6″″),57.4(C-7″″),98.6(C-1″),36.0(C-2″),79.0(C-3″),74.3(C-4″),71.3(C-5″),19.1(C-6″),58.1(C-7″)。以上数据与文献[13]对照鉴定该化合物为青阳参苷O。

化合物6 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.84(1H,m,H-3),5.27(1H,s,H-6),5.32(1H,dd,J=4.0,11.5 Hz,H-12),2.10(3H,s,H-18),1.29(3H,s,H-19),5.02(1H,q,J=6.0 Hz,H-20),1.56(3H,d,J=6.0 Hz,H-21),6.53(1H,d,J=16.0 Hz,H-2′),7.85(1H,d,J=16.0 Hz,H-3′),7.42(1H,m,H-5′),7.33(1H,m,H-6′),7.33(1H,m,H-7′),7.33(1H,m,H-8′),7.42(1H,m,H-9′),9.52(1H,s,H-2″),8.27(1H,d,J=8.0 Hz,H-4″),7.16(1H,dd,J=8.0,5.0,Hz,H-5″),8.80(1H,d,J=5.0 Hz,H-6″),5.29(1H,d,J=9.5 Hz,H-1),4.05(1H,m,H-3),3.51(1H,m,H-4),4.20(1H,m,H-5),1.38(3H,d,J=6.0 Hz,H-6),3.56(3H,s,H-7),5.12(1H,d,J=9.5 Hz,H-1″″),4.09(1H,m,H-3″″),3.60(1H,m,H-4″″),4.21(1H,m,H-5″″),1.40(3H,d,J=6.0 Hz,H-6″″),3.58(3H,s,H-7″″),4.76(1H,d,J=9.5 Hz,H-1″),3.58(1H,m,H-3″),3.49(1H,m,H-4″),3.61(1H,m,H-5″),1.58(3H,d,J=5.5 Hz,H-6″),3.45(3H,s,H-7″); 13C-NMR(pyridine-d5,125 MHz)δ:39.2(C-1),29.9(C-2),77.7(C-3),38.8(C-4),139.4(C-5),119.2(C-6),34.9(C-7),74.4(C-8),44.1(C-9),37.3(C-10),25.7(C-11),74.6(C-12),57.1(C-13),88.9(C-14),34.1(C-15),33.1(C-16),87.5(C-17),11.4(C-18),18.0(C-19),76.4(C-20),15.4(C-21),166.9(C-1′),120.3(C-2′),144.0(C-3′),134.9(C-4′),128.5(C-5′),129.2(C-6′),130.5(C-7′),129.2(C-8′),128.5(C-9′),164.6(C-1″),153.8(C-2″),127.0(C-3″),137.3(C-4″),123.0(C-5″),151.4(C-6″),96.4(C-1),37.2(C-2),78.0(C-3),83.4(C-4),69.0(C-5),18.6(C-6),58.9(C-7),100.4(C-1″″),37.3(C-2″″),77.9(C-3″″),83.2(C-4″″),69.1(C-5″″),18.6(C-6″″),58.8(C-7″″),102.0(C-1″),36.9(C-2″),81.4(C-3″),76.3(C-4″),73.0(C-5″), 18.6(C-6″),57.0(C-7″)。以上数据与文献[14-15]对照鉴定该化合物为加加明-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-加拿大麻吡喃糖苷。

化合物7 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.86(1H,m,H-3),5.26(1H,s,H-6),5.32(1H,dd,J=4.0,11.5 Hz,H-12),2.13(3H,s,H-18),1.33(3H,s,H-19),4.08(1H,q,J=6.0 Hz,H-20),1.30(3H,d,J=6.0 Hz,H-21),6.94(1H,d,J=16.0 Hz,H-2′),8.14(1H,d,J=16.0 Hz,H-3′),7.39(1H,m,H-5′),7.25(1H,m,H-6′),7.25(1H,m,H-7′),7.25(1H,m,H-8′),7.39(1H,m,H-9′),5.26(1H,d,J=9.5 Hz,H-1″),4.02(1H,m,H-3″),3.54(1H,m,H-4″),4.17(1H,m,H-5″),1.35(3H,d,J=6.0 Hz,H-6″),3.57(3H,s,H-7″),5.08(1H,d,J=9.5 Hz,H-1),4.02(1H,m,H-3),3.60(1H,m,H-4),4.19(1H,m,H-5),1.57(3H,d,J=6.0 Hz,H-6),3.52(3H,s,H-7),4.73(1H,d,J=9.5 Hz,H-1″″),3.90(1H,m,H-2″″),3.60(1H,m,H-3″″),3.57(1H,m,H-4″″),3.70(1H,m,H-5″″),1.56(3H,d,J=5.5 Hz,H-6″″),3.86(3H,s,H-7″″); 13C-NMR(pyridine-d5,125 MHz)δ:39.4(C-1),29.9(C-2),77.7(C-3),39.0(C-4),139.2(C-5),119.6(C-6),34.3(C-7),74.3(C-8),44.2(C-9),37.0(C-10),25.7(C-11),74.8(C-12),57.0(C-13),88.9(C-14),34.3(C-15),33.0(C-16),88.6(C-17),11.8(C-18),18.2(C-19),71.0(C-20),19.4(C-21),166.8(C-1′),119.7(C-2′),145.2(C-3′),135.1(C-4′),128.6(C-5′),129.2(C-6′),130.3(C-7′),129.2(C-8′),128.6(C-9′),96.4(C-1″),37.3(C-2″),78.2(C-3″),83.4(C-4″),69.1(C-5″),18.6(C-6″),58.9(C-7″),100.4(C-1),37.3(C-2),78.0(C-3),83.1(C-4),69.4(C-5),18.6(C-6),58.8(C-7),106.0(C-1″″),75.1(C-2″″),87.9(C-3″″),75.9(C-4″″),72.8(C-5″″),18.5(C-6″″),61.0(C-7″″)。以上数据与文献[16-17]对照鉴定该化合物为sinomarinoside B。

化合物8 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.84(1H,m,H-3),5.28(1H,s,H-6),5.20(1H,dd,J=4.0,11.5 Hz,H-12),2.03(3H,s,H-18),1.33(3H,s,H-19),2.49(3H,s,H-21),6.83(1H,d,J=16.0 Hz,H-2′),8.01(1H,d,J=16.0 Hz,H-3′),7.64(1H,m,H-5′),7.33(1H,m,H-6′),7.33(1H,m,H-7′),7.33(1H,m,H-8′),7.64(1H,m,H-9′),5.26(1H,d,J=9.5 Hz,H-1″),4.06(1H,m,H-3″),3.57(1H,m,H-4″),4.21(1H,m,H-5″),1.37(3H,d,J=6.0 Hz,H-6″),3.55(3H,s,H-7″),5.11(1H,d,J=9.5 Hz,H-1),4.06(1H,m,H-3),3.60(1H,m,H-4),4.21(1H,m,H-5),1.57(3H,d,J=6.0 Hz,H-6),3.60(3H,s,H-7),4.76(1H,d,J=10.0 Hz,H-1″″),3.92(1H,m,H-2″″),3.60(1H,m,H-3″″),3.57(1H,m,H-4″″),3.73(1H,m,H-5″″),1.59(3H,d,J=4.5 Hz,H-6″″),3.89(3H,s,H-7″″); 13C-NMR(pyridine-d5,125 MHz)δ:39.3(C-1),29.9(C-2),77.7(C-3),39.0(C-4),139.4(C-5),119.1(C-6),34.8(C-7),74.3(C-8),44.6(C-9),37.4(C-10),25.0(C-11),73.6(C-12),58.1(C-13),89.5(C-14),33.8(C-15),33.1(C-16),92.4(C-17),10.7(C-18),18.2(C-19),209.8(C-20),27.7(C-21),165.8(C-1′),119.2(C-2′),145.0(C-3′),135.1(C-4′),128.6(C-5′),129.2(C-6′),130.6(C-7′),129.2(C-8′),128.6(C-9′),96.4(C-1″),37.3(C-2″),78.2(C-3″),83.4(C-4″),69.4(C-5″),18.6(C-6″),58.8(C-7″),100.4(C-1),37.0(C-2),78.0(C-3),83.1(C-4),69.1(C-5),18.6(C-6),58.9(C-7),106.7(C-1″″),75.1(C-2″″),87.8(C-3″″),75.9(C-4″″),72.8(C-5″″),18.5(C-6″″),60.9(C-7″″)。以上数据与文献[16-18]对照鉴定该化合物为mucronatosides C。

化合物9 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.85(1H,m,H-3),5.28(1H,s,H-6),5.34(1H,dd,J=4.0,11.5 Hz,H-12),2.09(3H,s,H-18),1.30(3H,s,H-19),2.41(3H,s,H-21),8.30(1H,d,J=8.5 Hz,H-3′),7.22(1H,d,J=8.5 Hz,H-4′),7.22(1H,d,J=8.5 Hz,H-6′),8.30(1H,d,J=8.5 Hz,H-7′),5.29(1H,d,J=9.5 Hz,H-1″),4.09(1H,m,H-3″),3.54(1H,m,H-4″),4.17(1H,m,H-5″),1.38(3H,d,J=6.0 Hz,H-6″),3.57(3H,s,H-7″),5.12(1H,d,J=8.5 Hz,H-1),4.03(1H,m,H-3),3.45(1H,m,H-4),4.23(1H,m,H-5),1.38(3H,d,J=6.0 Hz,H-6),3.61(3H,s,H-7),4.70(1H,d,J=10.0 Hz,H-1″″),3.54(1H,m,H-3″″),3.50(1H,m,H-4″″),3.52(1H,m,H-5″″),1.47(3H,d,J=4.5 Hz,H-6″″),3.51(3H,s,H-7″″),4.97(1H,d,J=9.5 Hz,H-1″),3.47(1H,m,H-3″),3.47(1H,m,H-4″),3.59(1H,m,H-5″),1.59(3H,d,J=5.5 Hz,H-6″),3.47(3H,s,H-7″);13C-NMR(pyridine-d5,125 MHz)δ:39.3(C-1),29.9(C-2),77.7(C-3),38.9(C-4),139.5(C-5),119.1(C-6),34.8(C-7),74.4(C-8),44.5(C-9),37.4(C-10),25.2(C-11),73.4(C-12),58.4(C-13),89.5(C-14),33.9(C-15),33.2(C-16),92.5(C-17),10.8(C-18),18.2(C-19),209.7(C-20),27.8(C-21),165.4(C-1′),122.1(C-2′),132.4(C-3′),116.2(C-4′),163.6(C-5′),116.2(C-6′),132.4(C-7′),96.4(C-1″),37.3(C-2″),78.1(C-3″),83.4(C-4″),68.9(C-5″),18.7(C-6″),58.9(C-7″),100.5(C-1),37.4(C-2),77.8(C-3),83.2(C-4),69.1(C-5),18.7(C-6),58.8(C-7),102.0(C-1″″),37.6(C-2″″),79.1(C-3″″),82.7(C-4″″),71.7(C-5″″),18.6(C-6″″),57.3(C-7″″),100.3(C-1″),37.0(C-2″),81.7(C-3″),76.4(C-4″),73.0(C-5″),18.5(C-6″),57.0(C-7″)。以上数据与文献[19]对照鉴定该化合物为断节参苷J。

化合物10 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.88(1H,m,H-3),5.29(1H,s,H-6),5.33(1H,dd,J=4.0,11.5 Hz,H-12),2.09(3H,s,H-18),1.30(3H,s,H-19),5.04(1H,q,J=6.0 Hz,H-20),1.55(3H,d,J=6.0 Hz,H-21),6.56(1H,d,J=16.0 Hz,H-2′),7.86(1H,d,J=16.0 Hz,H-3′),7.43(1H,m,H-5′),7.35(1H,m,H-6′),7.35(1H,m,H-7′),7.35(1H,m,H-8′),7.43(1H,m,H-9′),9.54(1H,s,H-2″),8.31(1H,d,J=8.0 Hz,H-4″),7.17(1H,dd,J=8.0,5.0 Hz,H-5″),8.82(1H,d,J=5.0 Hz,H-6″),5.27(1H,d,J=9.5 Hz,H-1),4.07(1H,m,H-3),3.59(1H,m,H-4),4.22(1H,m,H-5),1.38(3H,d,J=6.0 Hz,H-6),3.56(3H,s,H-7),5.12(1H,d,J=9.5 Hz,H-1″″),4.07(1H,m,H-3″″),3.63(1H,m,H-4″″),4.22(1H,m,H-5″″),1.57(3H,d,J=6.0 Hz,H-6″″),3.62(3H,s,H-7″″),4.77(1H,d,J=9.5 Hz,H-1″),3.93(1H,m,H-2″),3.61(1H,m,H-3″),3.59(1H,m,H-4″),3.74(1H,m,H-5″),1.60(3H,d,J=6.0 Hz,H-6″),3.91(3H,s,H-7″);13C-NMR(pyridine-d5,125 MHz)δ: 39.3(C-1),29.9(C-2),77.7(C-3,38.8(C-4),139.4(C-5),119.2(C-6),34.9(C-7),74.4(C-8),44.1(C-9),37.3(C-10),25.7(C-11),74.6(C-12),57.2(C-13),88.9(C-14),34.1(C-15),33.7(C-16),87.5(C-17),11.4(C-18),18.1(C-19),76.4(C-20),15.4(C-21),166.7(C-1′),120.3(C-2′),144.0(C-3′),134.9(C-4′),128.5(C-5′),129.2(C-6′),130.5(C-7′),129.2(C-8′),128.5(C-9′),164.6(C-1″),153.8(C-2″),127.0(C-3″),137.3(C-4″),123.0(C-5″),151.4(C-6″),96.4(C-1),37.3(C-2),78.2(C-3),83.4(C-4),69.4(C-5),18.6(C-6),58.8(C-7),100.4(C-1″″),37.0(C-2″″),78.0(C-3″″),83.2(C-4″″),69.1(C-5″″),18.6(C-6″″),58.9(C-7″″),106.2(C-1″),75.1(C-2″),87.8(C-3″),75.9(C-4″),72.8(C-5″),18.5(C-6″),60.9(C-7″)。以上数据与文献[20]对照鉴定该化合物为stephanoside H。

化合物11 白色不定型粉末;1H-NMR(pyridine-d5,500 MHz)δ:3.87(1H,m,H-3),5.27(1H,s,H-6),5.33(1H,dd,J=4.0,11.0 Hz,H-12),2.09(3H,s,H-18),1.30(3H,s,H-19),2.42(3H,s,H-21),8.30(1H,d,J=8.5 Hz,H-3′),7.23(1H,d,J=8.5,H-4′),7.23(1H,d,J=8.5 Hz,H-6′),8.30(1H,d,J=8.5 Hz,H-7′),5.48(1H,d,J=9.5 Hz,H-1″),4.64(1H,m,H-3″),3.51(1H,m,H-4″),4.30(1H,m,H-5″),1.43(3H,d,J=6.0 Hz,H-6″),5.17(1H,d,J=9.5 Hz,H-1),4.05(1H,m,H-3),3.41(1H,m,H-4),4.20(1H,m,H-5),1.35(3H,d,J=6.0 Hz,H-6),3.56(3H,s,H-7),4.75(1H,d,J=10.0 Hz,H-1″″),3.48(1H,m,H-3″″),3.44(1H,m,H-4″″),3.59(1H,m,H-5″″),1.59(3H,d,J=4.5 Hz,H-6″″),3.45(3H,s,H-7″″);13C-NMR(pyridine-d5,125 MHz)δ: 39.3(C-1),29.9(C-2),77.7(C-3),39.0(C-4),139.6(C-5),118.9(C-6),34.8(C-7),74.4(C-8),44.5(C-9),37.4(C-10),25.2(C-11),73.4(C-12),58.5(C-13),89.6(C-14),33.9(C-15),33.2(C-16),92.5(C-17),10.8(C-18),18.2(C-19),209.7(C-20),27.8(C-21),165.4(C-1′),122.1(C-2′),132.4(C-3′),116.2(C-4′),163.6(C-5′),116.2(C-6′),132.4(C-7′),96.4(C-1″),39.0(C-2″),67.5(C-3″),83.4(C-4″),69.2(C-5″),18.5(C-6″),99.8(C-1),36.8(C-2),77.8(C-3),83.2(C-4),68.6(C-5),18.7(C-6),58.9(C-7),102.2(C-1″″),37.3(C-2″″),81.4(C-3″″),76.3(C-4″″),73.0(C-5″″),18.7(C-6″″),57.1(C-7″″)。以上数据与文献[21]对照鉴定该化合物为青阳参苷元-3-O-β-D-夹竹桃吡喃糖基-(14)-β-D-加拿大麻吡喃糖基-(14)-β-D-毛地黄毒吡喃糖苷。

[参考文献]

[1] 国家中医药管理局中华本草编委会. 中华本草. 第6卷[M]. 上海:上海科学技术出版社,1999:343.

[2] 赵益斌. 青阳参中化学成分的研究[D]. 昆明: 中国科学院昆明植物所,2004.

[3] 匡培根,吴义新,孟繁瑾,等. 青阳参治疗癫痫大发作——附动物实验观察 [J]. 中医杂志,1980,21(8): 22 .

[4] 木全章,周茜兰. 青阳参成分研究[J]. 中国植物研究,1983,5(1): 99.

[5] 木全章,周茜兰. 青阳参化学成分的研究[J]. 药学学报,1983,18(5): 356.

[6] 赵益斌,任虹燕,张培华,等. 从青阳参提取的带7个糖残基的新C21甾体苷[J]. 西南国防医学,2008,18(5): 625.

[7] Ma X X, Jiang F T, Yang Q X. New pregnane glycosides from the roots of Cynanchum otophyllum [J]. Steroids, 2007, 72: 776.

[8] 艾俊丽, 田猛, 杨庆雄. 青阳参C21甾体苷类化学成分研究进展[J]. 贵州师范大学学报:自然科学版, 2012, 18(4): 106.

[9] 木全章, 陆健荣, 周茜兰. 青洋参(Cynanchum otophyllum Schneid.)中抗癫痫成分——青洋参甙甲和乙的结构[J]. 中国科学B辑, 1985, 15(8): 724.

[10] Warashina T, Noro T. Steroidal glycosides from roots of Cynanchum caudatum M [J]. Chem Pharm Bull, 1995, 43(6): 977.

[11] Warashina T, Noro T. Steroidal glycosides from roots of Cynanchum caudatum M. Ⅱ [J]. Chem Pharm Bull, 1997, 42(10): 1734.

[12] 木全章, 沈月毛, 周茜兰, 等. 青阳参苷丙至苷庚五个化合物及其制备方法和应用中:中国, 1150951 [P]. 1997-06-04.

[13] Ma X X, Wang D, Zhang Y, et al. Identification of new qingyangshengenin and caudatin glycosides from the roots of Cynanchum otophyllum[J]. Steroids, 2011, 76(10):1003.

[14] Warashina T, Noro T. Steroidal glycosides from roots of Cynanchum caudatum M. III [J]. Chem Pharm Bull, 1996, 44(2): 358.

[15] Warashina T, Noro T. Steroidal glycosides from roots of Cynanchum caudatum [J]. Phytochemistry, 1997, 44(5): 917.

[16] Chen J, Zhang Z, Zhou J, et al. New pregnane glycosides fromSinomarsdenia incise [J]. J Nat Prod, 1999, 62(6): 829.

[17] Fumiko A, Hikaru O, Tatsuo Y, et al. Pregnane glycosides from Marsdenia tomentosa[J]. Chem Pharm Bull, 1994, 7(6): 869.

[18] Zhang R S, Ye Y P, Li X Y, et al. Oxypregnane-oligoglycosides from the stems of Stephanotis mucronata(Asclepiadaceae)[J]. Chin Chem Lett, 2005, 16(4): 483.

[19] 马晓霞. 五种药用植物的化学成分及其生物活性研究[D]. 昆明: 中国科学院昆明植物研究所, 2008.

[20] Li X, Sun H, Ye Y, et al. Three new immunomodulating C21-steroidal glycosides from the stems of Stephanotis mucronata [J]. Chem Biodivers, 2005, 2(12): 1701.

[21] Chen G, Xu N, Pei Y H, et al. C21 steroidal glycosides Cynanchum wallichii Wight[J]. J Asian Nat Prod Res, 2009, 2(11):177.

C21 steroids from roots of Cynanchum otophyllum

LI Xiang, ZHANG Mi, XIANG Cheng, QIN Yi, HE Jing, LI Bao-cai, LI Peng

(1.Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China;

2. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences

University of Macau, Macau 000856, China)

[Abstract] Eleven C21 steroids were isolated from chloroform extract of roots of Cynanchum otophyllumby silica gel, MCI, ODS columns, and semi-preparative HPLC. Their structures were determined by spectroscopic data analysis as otophylloside B(1), caudatin-3-O-β-D-cymaropyranosyl-(14)-β-D-oleandropyranosyl-(14)-β-D-cymaropyranosyl-(14)-β-D-cymaropyranoside(2), caudatin-3-O-β-D-oleandropyranosyl-(14)-β-D-oleandropyranosyl-(14)-β-D-cymaropyranosyl-(14)-β-D-cymaropyranoside(3), caudatin-3-O-β-D-oleandropyranosyl-(14)-β-D-digitoxopyranosyl-(14)-β-D-cymaropyranoside(4), otophylloside O(5), gagamine-3-O-β-D-oleandropyranosyl-(14)-β-D-cymaropyranosyl-(14)-β-D-cymaropyranoside(6), sinomarinoside B(7), mucronatosides C(8), wallicoside J(9), stephanoside H(10), and qinyangshengenin-3-O-β-D-oleandropyranosyl-(14)-β-D-cymaropyranosyl-(14)-β-D-digitoxopyranoside(11). Among them, compounds 2-3, and 6-11 were separated from the roots of this plant for the first time.

[Key words] Cynanchum otophyllum; C21 steroids; otophylloside B

doi:10.4268/cjcmm20140818

上一篇:试论大学辅导员的角色定位与工作方法 下一篇:如何在语文教学中培养学生的创造性思维能力